查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1300958

心房颤动市场规模、份额和趋势分析报告：按治疗类型、最终用途、地区、细分市场趋势：2023-2030

Atrial Fibrillation Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological Treatment, Non-Pharmacological Treatment), By End-use (Hospital, Specialty Clinics), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10个工作天内

价格

心房颤动市场增长和趋势

Grand View Research, Inc. 预计将继续发布新报告。

根据美国国立卫生研究院的数据，心房颤动影响着全球 3750 万人（占人口的 0.51%），在过去 20 年中增加了 33%。

此外，由于心房颤动影响着全世界数百万人，每年导致数千人住院和死亡，因此迫切需要创新的治疗方法和解决方案。 仅在美国，CDC 报告每年就有近 454,000 例因心房颤动住院治疗和超过 158,000 例死亡。 这些数字对于开发和营销用于房颤诊断、治疗和管理的新产品的公司来说代表着巨大的市场机会。

儘管心房颤动通常在急诊科接受治疗，但与大流行前相比，在 COVID-19 大流行期间因心房颤动初步诊断而住院的人数有所减少。我来了。 儘管如此，MDPI在2021年发表的一篇论文发现，高达7.5%的COVID-19患者可能会出现房颤，增加了房颤治疗的需求，我认为有可能。 然而，其他研究表明，患者行为的改变、房颤治疗的下降以及全球供应链中断导致某些医疗器械和器械短缺，导致了大流行期间出现持续性、阵发性房颤。痢疾患者就诊的次数减少。

政府批准的增加和主要参与者新产品的推出预计将推动心房颤动产品市场的增长。 例如，2023 年 3 月，美敦力的消融系统和 Affera Mapping 获得了 CE 标誌批准，用于通过 Affera Prism-1 Mapping 软件和 Sphere-9 导管治疗房性心律失常。 该系统集射频消融、脉衝场消融和高密度标测导管于一体，可实时反馈异常心律并提供精确的标测和消融，树立了电生理学的新标准。

心房颤动市场报告亮点

  • 根据治疗类型，心房颤动市场分为药物治疗和非药物治疗。 由于抗凝剂和抗心律失常药物的高需求，2022 年药物治疗领域在心房颤动市场中占据最大收入份额，超过 65%。
  • 根据最终用途，市场进一步细分为医院、专科诊所等。 预计到 2022 年，医院领域将占据最大的市场份额，预测期内復合年增长率最快，达到 10.4%。 该细分市场的快速增长主要是由于医院进行的手术数量较多。
  • 由于心房颤动的患病率和患病率不断增加，预计到 2022 年，北美将主导市场并占据最大收入份额，超过 39%。
  • 由于近年来医疗基础设施投资增加，预计亚太地区将以最快的速度增长，特别是在中国和印度等新兴经济体。

内容

第一章调查方法及范围

  • 市场细分和范围
  • 市场定义
  • 信息获取
    • 购买的数据库
    • GVR 内部数据库
    • 二手信息和第三方观点
    • 初步调查
    • 初步调查的详细信息
  • 信息分析
    • 数据分析模型
  • 市场形成和数据可视化
    • 产品流分析
  • 验证和发布数据
  • 全球市场：计算复合年增长率
  • 辅助信息列表
  • 主要信息列表

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第三章市场变量、趋势和范围

  • 市场细分和范围
  • 市场体系展望
    • 母公司市场前景
    • 相关/补充市场前景
  • 市场趋势和展望
  • 市场动态
  • 市场製约因素分析
  • 商业环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
  • COVID-19 感染的影响分析

第 4 章治疗类型的业务分析

  • 心房颤动市场（按治疗类型）：主要要点
  • 心房颤动市场：2022 年和 2030 年治疗类型趋势和市场份额分析
  • 药物治疗
    • 2018 年至 2030 年世界药物治疗市场估计和预测
    • 抗心律失常药物
    • 抗凝剂
  • 非药物治疗
    • 2018-2030 年世界非药物治疗市场估计和预测
    • 导管消融
    • 迷宫手术
    • 心臟復律

第 5 章最终用途业务分析

  • 心房颤动市场，按最终用途：主要要点
  • 心房颤动市场：2022 年和 2030 年最终用途变化和市场份额分析
  • 医院
    • 2018-2030 年全球医院市场估算和预测
  • 专科诊所
    • 2018-2030 年全球专科诊所市场估算和预测
  • 其他
    • 2018-2030 年其他全球市场预估和预测

第 6 章区域业务分析

  • 区域市场快照
  • 2022 年按地区划分的市场份额分析
  • 北美
    • 2018-2030 年北美房颤市场
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030 年欧洲心房颤动市场
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太地区心房颤动市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲心房颤动市场
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 2018-2030 年中东和非洲心房颤动市场
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第7章竞争格局

  • 公司分类
  • 战略规划
  • 公司简介列表
    • AtriCure Inc.
    • Boehringer Ingelheim GmbH
    • Boston Scientific Corporation.
    • Bristol-Myers Squibb Corporation
    • Cardio Focus Inc.
    • Sanofi Aventis
    • Biosense Webster Inc.
    • Endoscopic Technologies Inc.
    • Abbott（St. Jude Medical Inc.）
    • Johnsons &Johnson
Product Code: 978-1-68038-004-0

Atrial Fibrillation Market Growth & Trends

The global atrial fibrillation market size is expected to reach USD 48.01 billion by 2030, registering at a CAGR of 10.1%, according to a new report by Grand View Research, Inc.Aging population, lifestyle changes, and chronic diseases such as diabetes and obesity are factors contributing to the increasing incidence of atrial fibrillation (AFib). The National Institute of Health reports that AFib affects 37.5 million people globally (0.51% of the population), a 33% increase in the past 20 years.

Moreover, with millions worldwide affected by AFib, and thousands of hospitalizations and deaths annually, there is a critical need for innovative therapies and solutions. In the U.S. alone, the CDC reports almost 454,000 hospitalizations with AFib as the primary diagnosis each year, resulting in over 158,000 deaths. These numbers highlight a significant market opportunity for companies to develop and market new products for diagnosing, treating, and managing atrial fibrillation.

Atrial fibrillation is commonly treated in emergency departments, but during the COVID-19 pandemic, there has been a decrease in admissions for primary diagnoses of AF compared to pre-pandemic times. Despite this, the article published by MDPI in 2021 states that up to 7.5% of COVID-19 patients may develop AF, which could increase the demand for AF treatments. However, other studies have reported a decrease in visits by patients with persistent and paroxysmal atrial fibrillation during the pandemic, due to changes in patient behavior, a decline in AF procedures, and disruptions to global supply chains causing shortages of certain medical devices and equipment.

Increasing government approvals and new product launches by key players are expected to drive growth in the atrial fibrillation products market. For instance, in March 2023, Medtronic received CE Mark approval for its Ablation System and Affera Mapping, which is designed to treat atrial arrhythmias using the Affera Prism-1 Mapping Software and Sphere-9 Catheter. This system integrates radiofrequency, pulsed field ablation, and high-density mapping catheter to provide real-time feedback and accurate mapping and ablation of abnormal heart rhythms, creating a new standard in electrophysiology.

Atrial Fibrillation Market Report Highlights

  • Based on treatment type, the AFib market is segmented into pharmacological and non-pharmacological treatment. Pharmacological treatment segment held the largest revenue share of over 65% of the atrial fibrillation market in 2022, due to the high demand for anticoagulant drugs and anti-arrhythmic drugs
  • Based on end-use, the market has been further categorized into hospitals, specialty clinics, and others. The hospitals segment accounted for the largest share of the market in 2022, and it is estimated to register the fastest CAGR of 10.4% during the forecast period. The segment's rapid growth is primarily attributed to the high number of surgeries performed in hospitals
  • The North American region is expected to dominate the market and held the largest revenue share of over 39% in 2022, owing to the increasing incidence of atrial fibrillation and a large patient population
  • Asia Pacific is estimated to grow at the fastest rate during the forecast period due to the increasing investment in healthcare infrastructure in recent years, particularly in emerging economies such as China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Commodity Flow Analysis
      • 1.5.1.1. Approach 1: Commodity flow approach
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
  • 3.5. Market Restraint Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Treatment Type Business Analysis

  • 4.1. Atrial Fibrillation Market, By Treatment Type: Key Takeaways
  • 4.2. Atrial Fibrillation Market: Treatment Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Pharmacological Treatment
    • 4.3.1. Global Pharmacological Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Anti-arrhythmic Drugs
      • 4.3.2.1. Global Anti-arrhythmic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Anticoagulant Drugs
      • 4.3.3.1. Global Anticoagulant Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Non-Pharmacological Treatment
    • 4.4.1. Global Non-Pharmacological Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Catheter Ablation
      • 4.4.2.1. Global Catheter Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Radiofrequency
      • 4.4.2.2.1. Global Radiofrequency Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. HIFU
      • 4.4.2.3.1. Global HIFU Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.4. Cryoablation
      • 4.4.2.4.1. Global Cryoablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.5. Microwave
      • 4.4.2.5.1. Global Microwave Market Estimates and Forecasts, 2018 - 2030 (USD Million
      • 4.4.2.6. Laser
      • 4.4.2.6.1. Global Laser Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Maze Surgery
      • 4.4.3.1. Global Maze Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Electric Cardioversion
      • 4.4.4.1. Global Electric Cardioversion Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. End-Use Business Analysis

  • 5.1. Atrial Fibrillation Market, By End-Use: Key Takeaways
  • 5.2. Atrial Fibrillation Market: End-Use Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Global Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Specialty Clinics
    • 5.4.1. Global Specialty Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. Market Share Analysis by Region, 2022
  • 6.3. North America
    • 6.3.1. North America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Canada Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Germany Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.3. UK
      • 6.4.3.1. UK Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. France Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Italy Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Spain Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Denmark Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Sweden Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Norway Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. China Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. India Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. South Korea Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.6. Australia
      • 6.5.6.1. Australia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Thailand Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. South Africa Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Saudi Arabia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. UAE Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait Atrial Fibrillation Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Profiles/Listing
    • 7.3.1. AtriCure Inc.
      • 7.3.1.1. Overview
      • 7.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Boehringer Ingelheim GmbH
      • 7.3.2.1. Overview
      • 7.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Boston Scientific Corporation.
      • 7.3.3.1. Overview
      • 7.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Bristol- Myers Squibb Corporation
      • 7.3.4.1. Overview
      • 7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Cardio Focus Inc.
      • 7.3.5.1. Overview
      • 7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Sanofi Aventis
      • 7.3.6.1. Overview
      • 7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Biosense Webster Inc.
      • 7.3.7.1. Overview
      • 7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Endoscopic Technologies Inc.
      • 7.3.8.1. Overview
      • 7.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Abbott (St. Jude Medical Inc.)
      • 7.3.9.1. Overview
      • 7.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Johnsons & Johnson
      • 7.3.10.1. Overview
      • 7.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.10.3. Product Benchmarking
      • 7.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 3 Global Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 Global Atrial Fibrillation Market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Atrial Fibrillation Market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 7 North America Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 11 Canada Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Atrial Fibrillation Market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 14 Europe Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Germany Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 16 Germany Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 18 UK Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 France Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 20 France Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 22 Italy Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Spain Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 24 Spain Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Denmark Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 26 Denmark Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 28 Sweden Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Norway Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 30 Norway Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Atrial Fibrillation Market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 China Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 35 China Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Japan Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 37 Japan Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 India Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 39 India Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 South Korea Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 41 South Korea Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Australia Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 43 Australia Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Thailand Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 45 Thailand Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Latin America Atrial Fibrillation Market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 48 Latin America Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Brazil Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 50 Brazil Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Mexico Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 52 Mexico Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 54 Argentina Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 South Africa Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 58 South Africa Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 UAE Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 62 UAE Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Kuwait Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 64 Kuwait Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Atrial Fibrillation Market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration & growth prospect mapping, 2022
  • Fig. 15 Global Atrial Fibrillation Market: treatment type outlook key takeaways
  • Fig. 16 Global Atrial Fibrillation Market: treatment type movement analysis
  • Fig. 17 Pharmacological Treatment market, 2018 - 2030 (USD Million)
  • Fig. 18 Anti-arrhythmic Drugs market, 2018 - 2030 (USD Million)
  • Fig. 19 Anticoagulant Drugs market, 2018 - 2030 (USD Million)
  • Fig. 20 Non-Pharmacological Treatment market, 2018 - 2030 (USD Million)
  • Fig. 21 Catheter Ablation market, 2018 - 2030 (USD Million)
  • Fig. 22 Radiofrequency market, 2018 - 2030 (USD Million)
  • Fig. 23 HIFU market, 2018 - 2030 (USD Million)
  • Fig. 24 Cryoablation market, 2018 - 2030 (USD Million)
  • Fig. 25 Microwave market, 2018 - 2030 (USD Million)
  • Fig. 26 Laser market, 2018 - 2030 (USD Million)
  • Fig. 27 Maze Surgery market, 2018 - 2030 (USD Million)
  • Fig. 28 Electric Cardioversion market, 2018 - 2030 (USD Million)
  • Fig. 29 Global Atrial Fibrillation Market: end-use outlook key takeaways
  • Fig. 30 Global Atrial Fibrillation Market: end-use movement analysis
  • Fig. 31 Global Hospital market, 2018 - 2030 (USD Million)
  • Fig. 32 Global Specialty Clinics market, 2018 - 2030 (USD Million)
  • Fig. 33 Global others market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional marketplace: key takeaways
  • Fig. 35 Regional outlook, 2022 & 2030
  • Fig. 36 Global Atrial Fibrillation Market: region movement analysis
  • Fig. 37 North America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia pacific Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 51 China Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 52 India Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 56 Latin America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 57 Brazil Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 58 Mexico Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 60 Middle East and Africa Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 63 UAE Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 64 Kuwait Atrial Fibrillation Market, 2018 - 2030 (USD Million)